Biora Therapeutics Inc (BIOR)
0.7525
+0.02
(+2.94%)
USD |
NASDAQ |
May 06, 16:00
0.7525
0.00 (0.00%)
After-Hours: 20:00
Biora Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.064 |
| March 31, 2023 | -1.221 |
| December 31, 2022 | -1.250 |
| September 30, 2022 | -1.308 |
| June 30, 2022 | -1.322 |
| March 31, 2022 | -1.36 |
| December 31, 2021 | -1.487 |
| September 30, 2021 | -0.8891 |
| Date | Value |
|---|---|
| June 30, 2021 | -1.138 |
| March 31, 2021 | -1.292 |
| December 31, 2020 | -1.498 |
| September 30, 2020 | -1.204 |
| June 30, 2020 | -4.211 |
| March 31, 2020 | -0.8465 |
| December 31, 2019 | -0.8619 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-4.211
Minimum
Jun 2020
-0.8465
Maximum
Mar 2020
-1.397
Average
-1.250
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Eiger BioPharmaceuticals Inc | -2.844 |
| Disc Medicine Inc | -- |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 31.22M |
| Total Liabilities (Quarterly) | 132.64M |
| Shareholders Equity (Quarterly) | -101.42M |